Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies
- PMID: 25803438
- PMCID: PMC4372289
- DOI: 10.1371/journal.pone.0119313
Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies
Abstract
Background: Epidemiological studies have reported inconsistent association between obesity and risk of bladder cancer, and the dose-response relationship between them has not been clearly defined.
Methods: We carried out a meta-analysis to summarize available evidence from epidemiological studies on this point. Relevant articles were identified by searching the PubMed and Web of Science databases through September 30, 2014. We pooled the relative risks from individual studies using random-effect model, and the dose-response relationship was estimated by using restricted cubic spline model.
Results: Fifteen cohort studies with 38,072 bladder cancer cases among 14,201,500 participants were included. Compared to normal weight, the pooled relative risks and corresponding 95% confidence intervals of bladder cancer were 1.07(1.01-1.14) and 1.10(1.06-1.14) for preobese and obesity, with moderate (I² = 37.6%, P = 0.029) and low (I² = 15.5%, P = 0.241) heterogeneities between studies, respectively. In a dose-response meta-analysis, body mass index (BMI) was associated with bladder cancer risk in a linear fashion (P(non-linearity) = 0.467) and the risk increased by 4.2% for each 5 kg/m2 increase. No significant publication bias was found (P = 0.912 for Begg's test, P = 0.712 for Egger's test).
Conclusions: Findings from this dose-response meta-analysis suggest obesity is associated with linear-increased risk of bladder cancer.
Conflict of interest statement
Figures
![Fig 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4372289/bin/pone.0119313.g001.gif)
![Fig 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4372289/bin/pone.0119313.g002.gif)
![Fig 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4372289/bin/pone.0119313.g003.gif)
![Fig 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4372289/bin/pone.0119313.g004.gif)
Similar articles
-
Association of body mass index with bladder cancer risk: a dose-response meta-analysis of prospective cohort studies.Oncotarget. 2017 May 16;8(20):33990-34000. doi: 10.18632/oncotarget.16722. Oncotarget. 2017. PMID: 28389625 Free PMC article. Review.
-
Body mass index and risk of renal cell cancer: a dose-response meta-analysis of published cohort studies.Int J Cancer. 2014 Oct 1;135(7):1673-86. doi: 10.1002/ijc.28813. Epub 2014 Mar 6. Int J Cancer. 2014. PMID: 24615287
-
Obesity and risk of bladder cancer: a meta-analysis of cohort studies.Asian Pac J Cancer Prev. 2013;14(5):3117-21. doi: 10.7314/apjcp.2013.14.5.3117. Asian Pac J Cancer Prev. 2013. PMID: 23803089
-
Dietary flavonoids intake and the risk of coronary heart disease: a dose-response meta-analysis of 15 prospective studies.Thromb Res. 2015 Mar;135(3):459-63. doi: 10.1016/j.thromres.2014.12.016. Epub 2014 Dec 23. Thromb Res. 2015. PMID: 25555317
-
Association between obesity and bladder cancer recurrence: A meta-analysis.Clin Chim Acta. 2018 May;480:41-46. doi: 10.1016/j.cca.2018.01.039. Epub 2018 Feb 20. Clin Chim Acta. 2018. PMID: 29408169 Review.
Cited by
-
Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.Obes Pillars. 2022 Jul 5;3:100026. doi: 10.1016/j.obpill.2022.100026. eCollection 2022 Sep. Obes Pillars. 2022. PMID: 37990728 Free PMC article.
-
The Association between Dietary Inflammatory Potential and Urologic Cancers: A Meta-analysis.Adv Nutr. 2024 Jan;15(1):100124. doi: 10.1016/j.advnut.2023.09.012. Epub 2023 Nov 3. Adv Nutr. 2024. PMID: 37940476 Free PMC article. Review.
-
The role of SOD2 and NOS2 genes in the molecular aspect of bladder cancer pathophysiology.Sci Rep. 2023 Sep 2;13(1):14491. doi: 10.1038/s41598-023-41752-8. Sci Rep. 2023. PMID: 37660159 Free PMC article.
-
Body composition as a predictor of oncological outcome in patients with non-muscle-invasive bladder cancer receiving intravesical instillation after transurethral resection of bladder tumor.Front Oncol. 2023 Aug 10;13:1180888. doi: 10.3389/fonc.2023.1180888. eCollection 2023. Front Oncol. 2023. PMID: 37637042 Free PMC article.
-
Transcriptomic and Proteomic Analysis Reveals the Potential Role of RBMS1 in Adipogenesis and Adipocyte Metabolism.Int J Mol Sci. 2023 Jul 11;24(14):11300. doi: 10.3390/ijms241411300. Int J Mol Sci. 2023. PMID: 37511060 Free PMC article.
References
-
- Cancer IAFR. Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. Lyon, France: IARC; 2013.
-
- Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C. Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol. 2006;3: 327–340. - PubMed
-
- Vainio H, Bianchini F. Weight control and physical activity. IARC; 2002. - PubMed
-
- Smith M, Zhou M, Whitlock G, Yang G, Offer A, Hui G, et al. Esophageal cancer and body mass index: Results from a prospective study of 220,000 men in China and a meta-analysis of published studies. Int J Cancer. 2008;122: 1604–1610. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical